Inflammatory bowel disease drug trial starts by region

3 regions, 2020 to 2025

94 Global, 2025

Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 12 to 101. Latest values: Global 94 (2025); United States 37 (2025); China 31 (2025). 0 30 60 90 120 2020 2021 2022 2023 2024 2025 Global United States China
Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 12 to 101. Latest values: Global 94 (2025); United States 37 (2025); China 31 (2025). 0 30 60 90 120 2020 2021 2022 2023 2024 2025 Global United States China
Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 12 to 101. Latest values: Global 94 (2025); United States 37 (2025); China 31 (2025). 0 30 60 90 120 2020 2021 2022 2023 2024 2025 Global United States China
View the underlying data
Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025
Region Period Type Value
Global 2025 Actual 94
Global 2024 Actual 87
Global 2023 Actual 95
Global 2022 Actual 88
Global 2021 Actual 88
Global 2020 Actual 73
United States 2025 Actual 37
United States 2024 Actual 35
United States 2023 Actual 36
United States 2022 Actual 35
United States 2021 Actual 42
United States 2020 Actual 32
China 2025 Actual 31
China 2024 Actual 22
China 1 Jan 2023 to 27 Sep 2026 Actual 101
China 2022 Actual 18
China 2021 Actual 12
China 2020 Actual 12
Chart: StatOrigin · Source: ClinicalTrials.gov · statorigin.org CC BY 4.0